The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that two types of prescription-only Ranitidine medicines from Medley Pharma Limited are being recalled.
It said the pharma company was recalling all unexpired stock from pharmacies and retail stores as a precautionary measure.
Ranitidine 150mg and Ranitidine 300mg Tablets have been recalled due to possible contamination with an impurity N-nitrosodimethylamine which has genotoxic and carcinogenic potential.
MHRA had the following advice for healthcare professionals and wholesalers:
- Stop supplying the above products immediately and remove from the shelves within your store.
- Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
- If you receive queries about this issue from patients, advise them to contact their GP, pharmacist or healthcare professional to review ongoing treatment